Queensland Bauxite Limited (ASX:QBL) is pleased to announce preliminary findings in relation to cannabinoid testing performed by its subsidiary Medical Cannabis Limited of some of MCL's low THC Cannabis cultivars. (THC is tetrahydrocannabinol Delta 9, a medical compound produced by Cannabis plants).
Health & Pharm General
Anatara Lifesciences Limited (ASX:ANR) has today undertaken to extend by 12 months the expiry date of 250,000 Options which Anatara issued to the Pork Cooperative Research Centre in 2015.
The Board of Queensland Bauxite (ASX:QBL) is pleased to announce that the Department of Natural Resources and Mines has now formally approved the work programme intended under the MDL.
The following investment report by Edison titled 'Preparing for a clinical licence deal in Japan' has been published.
The Board of Queensland Bauxite (ASX:QBL) is delighted to announce that Mineral Development License approval has been progressed for the South Johnstone Bauxite Project at Camp Creek in Queensland with the important decision received today from the DEHP to approve the amendment to our previous Environmental Authority, to allow for the work programme intended under the MDL.
Pharmaxis Ltd (ASX:PXS) Boehringer Ingelheim is Initiating Phase IIa Study for the Development of a New Treatment for Diabetic Retinopathy - a Leading Cause of Vision-Loss
Boehringer Ingelheim and pharmaceutical research company Pharmaxis (ASX:PXS) (OTCMKTS:PXSLY) announce that Boehringer Ingelheim is initiating the Phase IIa study ROBIN. This marks the beginning of the clinical development program for BI 1467335 in a second indication targeting a severe diabetes complication. An already ongoing Phase II clinical study program is investigating the compound in NASH.
Boehringer Ingelheim Initiates Phase IIa Study of Compound Acquired from Pharmaxis Ltd (ASX:PXS) in Debilitating Liver Disease NASH
Boehringer Ingelheim and pharmaceutical company Pharmaxis (ASX:PXS) (OTCMKTS:PXSLY) announce that Boehringer Ingelheim has initiated a European and North American Phase IIa trial in NASH with BI 1467335 (formerly known as PXS-4728A), acquired from Pharmaxis in May 2015.
Banking & Finance
- FINANCE VIDEO: Graphex Mining Ltd (ASX:GPX) Metallurgical Test Work Significantly Enhances Flake Size & Drives Valuation Uplift
- East Coles Corporate Performance Awards 2017
- VIDEO: Echo Resources Ltd (ASX:EAR) Resource Upgrade at Orelia Surpasses Expectations and Underpins Production Strategy
Oil Gas & Energy
- Liquefied Natural Gas Ltd (ASX:LNG) 2017 Annual Report
- Elk Petroleum Limited (ASX:ELK) Completes A$27.5 Million Capital Raising
- Elk Petroleum Limited (ASX:ELK) to Acquire Aneth Oil Field and CO2 EOR Production Project